Home/Filings/4/0001209191-21-008085
4//SEC Filing

Colgan Erin 4

Accession 0001209191-21-008085

CIK 0001829802other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:38 PM ET

Size

5.8 KB

Accession

0001209191-21-008085

Insider Transaction Report

Form 4
Period: 2021-02-03
Colgan Erin
SVP of Finance
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-03+52,08352,083 total
    Exercise: $19.00Exp: 2031-02-02Common Stock (52,083 underlying)
Footnotes (1)
  • [F1]One-fourth (1/4th) of the options granted hereby shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, February 3, 2021, thereafter one forty-eighth (1/48th) of the options granted shall vest and become exercisable each month following the Vesting Commencement Date, over four years such that the options shall be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the grantee's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each such vesting date.

Issuer

Sensei Biotherapeutics, Inc.

CIK 0001829802

Entity typeother

Related Parties

1
  • filerCIK 0001843563

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:38 PM ET
Size
5.8 KB